The company said that its low-cost, high-throughput four-plex test could help to identify type 1 diabetes patients sooner and inform treatments to delay progression.

Having expanded access to quantitative hemoglobin variant testing in 40 countries, Hemex is now also setting its sights on the US and Europe.

Regulatory burdens have raised the capital requirements for early-stage companies, causing many to do what would have been ...

Researchers hope to soon commercialize a simple, inexpensive, and accessible screening test that uses taste as a detection ...

As the shutdown drags out, there could be delays in regulatory processes and payments for medical services as well as the possibility that legislative priorities will go unaddressed.

Sebia sells electrophoresis instruments and protein-based IVDs for use in multiple myeloma as well as metabolic, autoimmune, and inflammatory conditions.

The University of Washington spinout's test is used to detect and analyze protein biomarkers in a low-cost test, with results in 15-minutes.

An explosion in Medicare spending on epilepsy testing resembles a pattern of improper payments for genetic testing that was ...

NEW YORK – While blood has been, and remains, the gold standard for diagnostic testing, alternative sample types are attracting attention for their potential to unveil new diagnostic information and ...

The firm reported Wednesday that its third quarter Diagnostics revenues declined nearly 7 percent year over year.

NEW YORK – Roche on Monday announced that its blood-based Elecsys pTau181 test for assessment of Alzheimer's disease and other causes of cognitive decline has received clearance from the US Food and ...